Logothetis CJ - Search Results

1

Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential.

Assikis VJ, Do KA, Wen S, Wang X, Cho-Vega JH, Brisbay S, Lopez R, Logothetis CJ, Troncoso P, Papandreou CN, McDonnell TJ. Assikis VJ, et al. Among authors: logothetis cj. Clin Cancer Res. 2004 Oct 15;10(20):6770-8. doi: 10.1158/1078-0432.CCR-04-0275. Clin Cancer Res. 2004. PMID: 15501953

2

Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases.

Grignon DJ, Ro JY, Ayala AG, Shum DT, Ordóñez NG, Logothetis CJ, Johnson DE, Mackay B. Grignon DJ, et al. Among authors: logothetis cj. Cancer. 1992 Jan 15;69(2):527-36. doi: 10.1002/1097-0142(19920115)69:2<527::aid-cncr2820690241>3.0.co;2-7. Cancer. 1992. PMID: 1309435

3

Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.

Logothetis CJ, Xu HJ, Ro JY, Hu SX, Sahin A, Ordonez N, Benedict WF. Logothetis CJ, et al. J Natl Cancer Inst. 1992 Aug 19;84(16):1256-61. doi: 10.1093/jnci/84.16.1256. J Natl Cancer Inst. 1992. PMID: 1640485

4

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

5

The clinical and biological study of androgen independent prostate cancer (AI PCa).

Logothetis CJ, Hoosein NM, Hsieh JT. Logothetis CJ, et al. Semin Oncol. 1994 Oct;21(5):620-9. Semin Oncol. 1994. PMID: 7524155 Review. No abstract available.

6

The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.

Daliani DD, Eisenberg PD, Weems J, Lord R, Fueger R, Logothetis CJ. Daliani DD, et al. Among authors: logothetis cj. J Urol. 1995 May;153(5):1587-91. J Urol. 1995. PMID: 7536271 Clinical Trial.

7

Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.

Sella A, Aggarwal BB, Kilbourn RG, Bui CA, Zukiwski AA, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. Cancer Biother. 1995 Fall;10(3):225-35. doi: 10.1089/cbr.1995.10.225. Cancer Biother. 1995. PMID: 8547961 Clinical Trial.

8

Serum calcitonin in small cell carcinoma of the prostate.

Sim SJ, Glassman AB, Ro JY, Lee JJ, Logothetis CJ, Liu FJ. Sim SJ, et al. Among authors: logothetis cj. Ann Clin Lab Sci. 1996 Nov-Dec;26(6):487-95. Ann Clin Lab Sci. 1996. PMID: 8908318

9

Expression of bcl-2 oncoprotein and p53 protein accumulation in bone marrow metastases of androgen independent prostate cancer.

McDonnell TJ, Navone NM, Troncoso P, Pisters LL, Conti C, von Eschenbach AC, Brisbay S, Logothetis CJ. McDonnell TJ, et al. Among authors: logothetis cj. J Urol. 1997 Feb;157(2):569-74. J Urol. 1997. PMID: 8996359

10

Phase II trial of 5-fluorouracil, interferon-alpha and continuous infusion interleukin-2 for patients with metastatic renal cell carcinoma.

Ellerhorst JA, Sella A, Amato RJ, Tu SM, Millikan RE, Finn LD, Banks M, Logothetis CJ. Ellerhorst JA, et al. Among authors: logothetis cj. Cancer. 1997 Dec 1;80(11):2128-32. Cancer. 1997. PMID: 9392335 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

421 results

Search Page

Filters